Literature DB >> 15278761

CTLA4 exon 1 polymorphism, rheumatoid arthritis and autoimmune endocrinopathy.

Steven Young-Min, Bijay Vaidya.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15278761     DOI： 10.1007/s10067-004-0949-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  10 in total

1.  The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus.

Authors:  B Vaidya; H Imrie; P Perros; E T Young; W F Kelly; D Carr; D M Large; A D Toft; M I McCarthy; P Kendall-Taylor; S H Pearce
Journal:  Hum Mol Genet       Date:  1999-07       Impact factor: 6.150

2.  Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.

Authors:  Hironori Ueda; Joanna M M Howson; Laura Esposito; Joanne Heward; Hywel Snook; Giselle Chamberlain; Daniel B Rainbow; Kara M D Hunter; Annabel N Smith; Gianfranco Di Genova; Mathias H Herr; Ingrid Dahlman; Felicity Payne; Deborah Smyth; Christopher Lowe; Rebecca C J Twells; Sarah Howlett; Barry Healy; Sarah Nutland; Helen E Rance; Vin Everett; Luc J Smink; Alex C Lam; Heather J Cordell; Neil M Walker; Cristina Bordin; John Hulme; Costantino Motzo; Francesco Cucca; J Fred Hess; Michael L Metzker; Jane Rogers; Simon Gregory; Amit Allahabadia; Ratnasingam Nithiyananthan; Eva Tuomilehto-Wolf; Jaakko Tuomilehto; Polly Bingley; Kathleen M Gillespie; Dag E Undlien; Kjersti S Rønningen; Cristian Guja; Constantin Ionescu-Tîrgovişte; David A Savage; A Peter Maxwell; Dennis J Carson; Chris C Patterson; Jayne A Franklyn; David G Clayton; Laurence B Peterson; Linda S Wicker; John A Todd; Stephen C L Gough
Journal:  Nature       Date:  2003-04-30       Impact factor: 49.962

3.  CTLA-4 gene polymorphism in promoter and exon-1 regions is not associated with Chinese patients with rheumatoid arthritis.

Authors:  Ming-Fei Liu; Chrong-Reen Wang; Pei-Chih Chen; Tsung-Liang Lin
Journal:  Clin Rheumatol       Date:  2004-01-28       Impact factor: 2.980

4.  An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies.

Authors:  B Vaidya; S H S Pearce; S Charlton; N Marshall; A D Rowan; I D Griffiths; P Kendall-Taylor; T E Cawston; S Young-Min
Journal:  Rheumatology (Oxford)       Date:  2002-02       Impact factor: 7.580

5.  Thyroid dysfunction in rheumatoid arthritis: a controlled prospective survey.

Authors:  J B Shiroky; M Cohen; M L Ballachey; C Neville
Journal:  Ann Rheum Dis       Date:  1993-06       Impact factor: 19.103

6.  Association of CTLA4 gene A-G polymorphism with rheumatoid arthritis in Chinese.

Authors:  C-S Lee; Y-J Lee; H-F Liu; C-H Su; S-C Chang; B-R Wang; T-L Chen; T-L Liu
Journal:  Clin Rheumatol       Date:  2003-09       Impact factor: 2.980

7.  Prevalence of thyroid abnormalities in patients with rheumatoid arthritis.

Authors:  P Caron; S Lassoued; C Dromer; F Oksman; A Fournie
Journal:  Thyroidology       Date:  1992-12

8.  Genetic interrelationship between insulin-dependent diabetes mellitus, the autoimmune thyroid diseases, and rheumatoid arthritis.

Authors:  C P Torfs; M C King; B Huey; J Malmgren; F C Grumet
Journal:  Am J Hum Genet       Date:  1986-02       Impact factor: 11.025

9.  Haplotype analysis in simplex families and novel analytic approaches in a case-control cohort reveal no evidence of association of the CTLA-4 gene with rheumatoid arthritis.

Authors:  Anne Barton; Francine Jury; Stephen Eyre; John Bowes; Anne Hinks; Daniel Ward; Jane Worthington
Journal:  Arthritis Rheum       Date:  2004-03

10.  The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry.

Authors:  L Nisticò; R Buzzetti; L E Pritchard; B Van der Auwera; C Giovannini; E Bosi; M T Larrad; M S Rios; C C Chow; C S Cockram; K Jacobs; C Mijovic; S C Bain; A H Barnett; C L Vandewalle; F Schuit; F K Gorus; R Tosi; P Pozzilli; J A Todd
Journal:  Hum Mol Genet       Date:  1996-07       Impact factor: 6.150
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.